服薬アドヒアランスの世界市場規模・シェア・開発・成長・需要予測(2013~2023年):商品別(ソフトウェアセントリック、ハードウェアセントリック)・症状別(心臓、CNS、肥満、腫瘍、呼吸、消化管、リウマチ)・地域別(米国、カナダ、ドイツ、フランス、イギリス、日本、中国)

P&S Market Researchが発行した調査報告書(PSM802120)
◆英語タイトル:Medication Adherence Market by Product (Software Centric, Hardware Centric), by Medication (Cardiovascular, CNS, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology), by Geography (U.S., Canada, Germany, France, U.K., Japan, China) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023
◆商品コード:PSM802120
◆発行会社(リサーチ会社):P&S Market Research
◆発行日:2017年11月1日
◆ページ数:191
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD6,100 ⇒換算¥689,300見積依頼/購入/質問フォーム
Group License(5名様閲覧用)USD7,100 ⇒換算¥802,300見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD10,100 ⇒換算¥1,141,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はP&S Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。P&S Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

The growth in the market will be led by the growing demand for advanced medication adherence systems, increasing prevalence of chronic diseases, rising geriatric population, increasing demand for mobile health (mHealth) technologies, and expanding demand for personalized healthcare technologies.
Insights on market segments

In terms of product type, the medication adherence market has been categorized as software centric and hardware centric, where software centric occupied a larger share in the global market in 2016. Hardware centric products are projected to register faster growth during the forecast period, at a CAGR of 13.1%. This is substantiated by the fact that the major players in the market are focused on launching hardware centric products, such as Smart Wireless Pill Bottles by AdhereTech, Inc., and HealthAssist Watch by Adherence Solutions, LLC, that improve and track adherence in real time.

By medication, the medication adherence market is predicted to be led by demand for the products used for compliance in cardiovascular diseases, both in terms of size and growth. The leading position of the category is due to the increasing cases of cardiovascular diseases across the globe. As per the 2015 global data from WHO, out of 17.7 million deaths caused by cardiovascular diseases, approximately 7.4 million deaths were due to coronary heart disease and 6.7 million were due to stroke.

North America stands as the largest market for medication adherence

North America held the largest medication adherence market share in 2016. This large contribution is mainly driven by the increase in R&D infrastructure, growing aging population, expanding healthcare expenditure, and increasing prevalence of chronic diseases in the region. According to the Centers for Disease Control and Prevention (CDC), the total national healthcare expenditure in the U.S. was $3.2 trillion in 2015 and per capita national health expenditure was $9,990. Additionally, the healthcare expenditure as a percentage of GDP was 17.8%, and the total investment in R&D (Medical and Health) for 2015 was around $158.7 billion in the U.S.

Major players in the market are launching new and innovative products to gain a larger share

Globally, the key providers in the medication adherence industry are launching new products to gain a larger market share. For instance, in May 2017, DrFirst.com Inc., a clinical software and services provider, announced the launch of SmartSig and PDMP Access Solutions that exemplify intelligent medication management, compliance adherence, and simplification of clinical workflows. The products offer enhance data quality, improve clinical workflow and deliver stronger adherence to therapy. Both SmartSig and PDMP Access Solutions fully integrate with the company’s suite of intelligent medication management products.

The key players operating in the medication adherence market include Koninklijke Philips N.V., Cardinal Health Inc., Omnicell Inc., McKesson Corporation, Johnson & Johnson Services, Inc., Proteus Digital Health, Inc., AdhereTech Inc., Qualcomm Incorporated, Adherence Solutions LLC, and SMRxT Inc.

【レポートの目次】

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Medication

1.3.3 Market Segmentation by Geography

1.3.4 Analysis Period

1.3.5 Market Data Reporting Unit

1.3.5.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 Hardware centric product

4.1.1.1.1 By device

4.1.1.1.1.1 Automated dispensing systems

4.1.1.1.1.2 Smart pill bottles

4.1.1.1.1.3 Electronic trays

4.1.1.1.1.4 Other devices

4.1.1.1.2 By packaging

4.1.1.1.2.1 Multi dose

4.1.1.1.2.2 Unit dose

4.1.1.2 Software centric product

4.1.1.2.1 Mobile based apps

4.1.1.2.2 Other apps

4.1.2 By Medication

4.1.2.1 Cardiovascular

4.1.2.2 CNS

4.1.2.3 Diabetes

4.1.2.4 Oncology

4.1.2.5 Gastrointestinal

4.1.2.6 Rheumatology

4.1.2.7 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing use of smartphone medication adherence apps

4.2.1.2 Rising awareness for medication adherence through patient saving programs

4.2.1.3 Growing popularity of medication adherence systems and software

4.2.2 Drivers

4.2.2.1 Growing demand for advanced medication adherence systems

4.2.2.2 Increasing prevalence of chronic diseases

4.2.2.3 Rising geriatric population

4.2.2.4 Increasing demand for mHealth technologies

4.2.2.5 Expanding demand for personalized healthcare

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Privacy and security concerns in the EHR and e-prescribing based medication adherence systems

4.2.3.2 Inadequate healthcare infrastructure in developing economies

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Vast unexplored medication adherence market across the globe

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Intensity of Rivalry

4.3.4 Threat of New Entrants

4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.1.1 Software Centric Market

5.1.1.1 By type

5.1.2 Hardware Centric Market

5.1.2.1 By device

5.1.2.2 By packaging

5.2 By Medication

5.3 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Product

6.1.1 Software Centric Market

6.1.1.1 By type

6.1.2 Hardware Centric Market

6.1.2.1 By device

6.1.2.2 By packaging

6.2 By Medication

6.3 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Product

7.1.1 Software Centric Market

7.1.1.1 By type

7.1.2 Hardware Centric Market

7.1.2.1 By device

7.1.2.2 By packaging

7.2 By Medication

7.3 By Country

Chapter 8. Asia-Pacific Market Size and Forecast

8.1 By Product

8.1.1 Software Centric Market

8.1.1.1 By type

8.1.2 Hardware Centric Market

8.1.2.1 By device

8.1.2.2 By packaging

8.2 By Medication

8.3 By Country

Chapter 9. Rest of the World (RoW) Market Size and Forecast

9.1 By Product

9.1.1 Software Centric Market

9.1.1.1 By type

9.1.2 Hardware Centric Market

9.1.2.1 By device

9.1.2.2 By packaging

9.2 By Medication

Chapter 10. Medication Adherence Product Analysis

10.1 Hardware Centric Products

10.1.1 HealthAssist Watch

10.1.1.1 Overview

10.1.1.2 Pros

10.1.1.3 Cons

10.1.2 Philips Automated Medication Dispenser

10.1.2.1 Overview

10.1.2.2 Pros

10.1.2.3 Cons

10.1.2.4 Efficacy

10.1.3 2net Hub

10.1.3.1 Overview

10.1.3.2 Pros

10.1.3.3 Cons

10.1.4 Proteus Discover

10.1.4.1 Overview

10.1.4.2 Pros

10.1.4.3 Cons

10.1.4.4 Efficacy

10.1.5 Omnicell Xt

10.1.5.1 Overview

10.1.5.2 Pros

10.1.5.3 Cons

10.1.6 Smart Wireless Pill Bottles

10.1.6.1 Overview

10.1.6.2 Pros

10.1.6.3 Cons

10.1.6.4 Efficacy

10.1.7 Nomi Pill Bottle

10.1.7.1 Overview

10.1.7.2 Pros

10.1.7.3 Cons

10.1.8 Cardinal Health Repackaging Solutions

10.1.8.1 Overview

10.1.8.2 Pros

10.1.8.3 Cons

10.1.9 Dispill

10.1.9.1 Overview

10.1.9.2 Pros

10.1.9.3 Cons

10.2 Software Centric Products

10.2.1 RelayRx PriorAuthPlus

10.2.1.1 Overview

10.2.1.2 Pros

10.2.1.3 Cons

10.2.2 Adherence Performance Solution

10.2.2.1 Overview

10.2.2.2 Pros

10.2.2.3 Cons

10.2.3 eVoucherRx

10.2.3.1 Overview

10.2.3.2 Pros

10.2.3.3 Cons

10.2.4 RelayRx Continuity of Care

10.2.4.1 Overview

10.2.4.2 Pros

10.2.4.3 Cons

10.2.5 Care4Today

10.2.5.1 Overview

10.2.5.2 Pros

10.2.5.3 Cons

10.2.6 PatientAdvisor

10.2.6.1 Overview

10.2.6.2 Pros

10.2.6.3 Cons

10.2.7 2net Mobile and 2net Platform

10.2.7.1 Overview

10.2.7.2 Pros

10.2.7.3 Cons

10.2.8 HealthAssist

10.2.8.1 Overview

10.2.8.2 Pros

10.2.8.3 Cons

10.2.9 Pharmacy Health Connect

10.2.9.1 Overview

10.2.9.2 Pros

10.2.9.3 Cons

10.2.10 Prescription Reminder Service — Local Store Marketing

10.2.10.1 Overview

10.2.10.2 Pros

10.2.10.3 Cons

10.2.11 Medication Therapy Management Solution

10.2.11.1 Overview

10.2.11.2 Pros

10.2.11.3 Cons

10.3 Products Adopted by Pharmaceutical/ Biopharmaceutical Companies

10.3.1 Smart Pill Bottles, Boxes and Caps

10.3.2 AI Based Approach

10.3.3 Ingestible Sensors

10.3.4 Automation of Directly Observed Therapy (DOT)

10.3.5 Connected Devices

10.3.6 Interactive Software Changing Patient Behavior Through Incentives

10.3.7 Smart Injectors

10.3.8 Mobile Applications/Software

10.4 Regional Analysis for Medication Adherence Market

10.4.1 North America

10.4.1.1 Key trends/legislations/regulations

10.4.1.2 Impact analysis

10.4.1.3 Impact of healthcare systems on North America medication adherence market

10.4.2 Asia-Pacific

10.4.2.1 Key trends/legislations/regulations

10.4.2.2 Impact analysis

10.4.2.3 Impact of healthcare systems on Asia-Pacific medication adherence market

10.4.3 Latin America

10.4.3.1 Key trends/legislations/regulations

10.4.3.2 Impact analysis

10.4.3.3 Impact of healthcare systems on Latin America medication adherence market

10.4.4 EMEA

10.4.4.1 Key trends/legislations/regulations

10.4.4.2 Impact analysis

10.4.4.3 Impact of healthcare systems on EMEA medication adherence market

10.5 Clinical Trial Impact for Non-Adherence

Chapter 11. Competitive Landscape

11.1 Global Company Share Analysis

11.1.1 Hardware Centric Medication Adherence Market Share of Key Players

11.1.2 Software Centric Medication Adherence Market Share of Key Players

11.2 Share of Wallet (SOW) Analysis

11.3 Competitive Benchmarking of Key Players

11.4 Global Strategic Developments of Key Players

11.4.1 Merger and Acquisition

11.4.2 Product Launch

11.4.3 Partnership

Chapter 12. Company Profiles

12.1 Global Key Players

12.1.1 Koninklijke Philips N.V.

12.1.1.1 Business Overview

12.1.1.2 Product and Service Offerings

12.1.1.3 Koninklijke Philips N.V. Key Financial Summary

12.1.1.4 Strategic Growth Plans

12.1.2 Qualcomm Incorporated

12.1.2.1 Business Overview

12.1.2.2 Product and Service Offerings

12.1.2.3 Qualcomm Incorporated Key Financial Summary

12.1.2.4 Strategic Growth Plans

12.1.3 Proteus Digital Health, Inc.

12.1.3.1 Business Overview

12.1.3.2 Product and Service Offerings

12.1.4 AdhereTech, Inc.

12.1.4.1 Business Overview

12.1.4.2 Product and Service Offerings

12.1.5 McKesson Corporation

12.1.5.1 Business Overview

12.1.5.2 Product and Service Offerings

12.1.5.3 McKesson Corporation Key Financial Summary

12.1.5.4 Strategic Growth Plans

12.1.6 Omnicell, Inc.

12.1.6.1 Business Overview

12.1.6.2 Product and Service Offerings

12.1.6.3 Omnicell, Inc. Key Financial Summary

12.1.6.4 Strategic Growth Plans

12.1.7 Adherence Solutions, LLC

12.1.7.1 Business Overview

12.1.7.2 Product and Service Offerings

12.1.8 SMRxT Inc.

12.1.8.1 Business Overview

12.1.8.2 Product and Service Offerings

12.1.8.3 Strategic Growth Plans

12.1.9 DrFirst.com, Inc.

12.1.9.1 Business Overview

12.1.9.2 Product and Service Offerings

12.1.10 Cardinal Health, Inc.

12.1.10.1 Business Overview

12.1.10.2 Product and Service Offerings

12.1.10.3 Cardinal Health, Inc. Key Financial Summary

12.1.10.4 Strategic Growth Plans

12.1.11 Johnson & Johnson

12.1.11.1 Business overview

12.1.11.2 Product and service offerings

12.1.11.3 Johnson & Johnson Key Financial Summary

12.1.11.4 Strategic growth plans

Chapter 13. Appendix

13.1 Abbreviations

13.2 Related Reports

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 5 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 6 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 7 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 8 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2016)

TABLE 9 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2017 – 2023)

TABLE 10 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2016)

TABLE 11 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2017 – 2023)

TABLE 12 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2016)

TABLE 13 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2017 – 2023)

TABLE 14 GLOBAL MEDICATION ADHERENCE MARKET, BY REGION, $M (2013 – 2016)

TABLE 15 GLOBAL MEDICATION ADHERENCE MARKET, BY REGION, $M (2017 – 2023)

TABLE 16 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 17 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 18 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 19 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 20 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2016)

TABLE 21 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2017 – 2023)

TABLE 22 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2016)

TABLE 23 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2017 – 2023)

TABLE 24 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2016)

TABLE 25 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2017 – 2023)

TABLE 26 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 27 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 28 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 29 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 30 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 31 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 32 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2016)

TABLE 33 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2017 – 2023)

TABLE 34 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2016)

TABLE 35 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2017 – 2023)

TABLE 36 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2016)

TABLE 37 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2017 – 2023)

TABLE 38 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 39 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 40 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 41 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 42 ASIA-PACIFIC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 43 ASIA-PACIFIC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 44 ASIA-PACIFIC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2016)

TABLE 45 ASIA-PACIFIC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2017 – 2023)

TABLE 46 ASIA-PACIFIC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2016)

TABLE 47 ASIA-PACIFIC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2017 – 2023)

TABLE 48 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2016)

TABLE 49 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2017 – 2023)

TABLE 50 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 51 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 52 ROW MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 53 ROW MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 54 ROW SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2016)

TABLE 55 ROW SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2017 – 2023)

TABLE 56 ROW HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2016)

TABLE 57 ROW HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2017 – 2023)

TABLE 58 ROW HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2016)

TABLE 59 ROW HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2017 – 2023)

TABLE 60 ROW MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2016)

TABLE 61 ROW MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2017 – 2023)

TABLE 62 KONINKLIJKE PHILIPS N.V. – AT A GLANCE

TABLE 63 QUALCOMM INCORPORATED – AT A GLANCE

TABLE 64 PROTEUS DIGITAL HEALTH, INC. – AT A GLANCE

TABLE 65 ADHERETECH, INC. – AT A GLANCE

TABLE 66 MCKESSON CORPORATION – AT A GLANCE

TABLE 67 OMNICELL, INC. – AT A GLANCE

TABLE 68 ADHERENCE SOLUTIONS, LLC – AT A GLANCE

TABLE 69 SMRXT INC. – AT A GLANCE

TABLE 70 DR FIRST.COM, INC. – AT A GLANCE

TABLE 71 CARDINAL HEALTH, INC. – AT A GLANCE

TABLE 72 JOHNSON & JOHNSON – AT A GLANCE

LIST OF FIGURES

FIG 1 RESEARCH METHODOLOGY

FIG 2 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 GLOBAL MEDICATION ADHERENCE MARKET SUMMARY

FIG 8 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION REGION

FIG 9 MAJOR CATEGORIES OF MHEALTH APPLICATIONS AND MEDICATION ADHERENCE

FIG 10 PORTER’S FIVE FORCES ANALYSIS

FIG 11 SNAPSHOT OF MEDICATION ADHERENCE MARKET, BY PRODUCT (2016)

FIG 12 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 13 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2023)

FIG 14 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE PRODUCT MARKET, BY DEVICE, $M (2013 – 2023)

FIG 15 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE PRODUCT MARKET, BY PACKAGING, $M (2013 – 2023)

FIG 16 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2023)

FIG 17 WORLDWIDE MAJOR MARKETS FOR MEDICATION ADHERENCE

FIG 18 NORTH AMERICA MEDICATION ADHERENCE MARKET SNAPSHOT

FIG 19 PERCENTAGE OF POPULATION AGED 60 YEARS OR ABOVE AND 80 YEARS OR ABOVE

FIG 20 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 21 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2023)

FIG 22 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2023)

FIG 23 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2023)

FIG 24 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2023)

FIG 25 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2013 – 2016)

FIG 26 EUROPE MEDICATION ADHERENCE MARKET SNAPSHOT

FIG 27 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 28 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2023)

FIG 29 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2023)

FIG 30 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2023)

FIG 31 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2023)

FIG 32 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 33 ASIA-PACIFIC MEDICATION ADHERENCE MARKET SNAPSHOT

FIG 34 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 35 ASIA-PACIFIC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2023)

FIG 36 ASIA-PACIFIC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2023)

FIG 37 ASIA-PACIFIC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2023)

FIG 38 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2023)

FIG 39 ASIA-PACIFIC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2013 – 2016)

FIG 40 ROW MEDICATION ADHERENCE MARKET SNAPSHOT

FIG 41 ROW MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 42 ROW SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2013 – 2023)

FIG 43 ROW HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICE, $M (2013 – 2023)

FIG 44 ROW HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2013 – 2023)

FIG 45 ROW MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2013 – 2023)

FIG 46 GLOBAL MARKET SHARE OF KEY PLAYERS (2016)

FIG 47 HARDWARE CENTRIC MEDICATION ADHERENCE MARKET SHARE OF KEY PLAYERS (2016)

FIG 48 SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET SHARE OF KEY PLAYERS (2016)

FIG 49 GLOBAL SHARE OF WALLET ANALYSIS OF KEY PLAYERS FOR HARDWARE CENTRIC AND SOFTWARE CENTRIC (2016)

FIG 50 COMPETITIVE BENCHMARKING OF KEY PLAYERS

FIG 51 KONINKLIJKE PHILIPS N.V. REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2016)

FIG 52 QUALCOMM INCORPORATED REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 53 MCKESSON CORPORATION REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 54 OMNICELL, INC. REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2016)

FIG 55 CARDINAL HEALTH, INC. REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 56 JOHNSON & JOHNSON REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 服薬アドヒアランスの世界市場規模・シェア・開発・成長・需要予測(2013~2023年):商品別(ソフトウェアセントリック、ハードウェアセントリック)・症状別(心臓、CNS、肥満、腫瘍、呼吸、消化管、リウマチ)・地域別(米国、カナダ、ドイツ、フランス、イギリス、日本、中国)(Medication Adherence Market by Product (Software Centric, Hardware Centric), by Medication (Cardiovascular, CNS, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology), by Geography (U.S., Canada, Germany, France, U.K., Japan, China) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆